Error loading player: No playable sources found
3500
Therapeutic Choice and the Pipeline for MASLD and MASH
Date
May 19, 2024
SOCIETY: AASLD
Moderators
The University of Alabama at Birmingham
Thomas Jefferson University
Tracks
Related Products
It's Not Over: Viral Hepatitis in the Modern Era
SOCIETY: AASLD
Experiments In Alcohol-Associated Liver Disease
SOCIETY: AASLD
Human and Experimental Cholestasis
METABOLIC OUTCOMES AND KEY EFFICACY DATA FROM A PHASE 2 TRIAL EVALUATING COMBINATION OBETICHOLIC ACID AND BEZAFIBRATE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
